Mike Schwaebe

Mike Schwaebe has a diverse work experience in the pharmaceutical and biopharmaceutical industries. Mike is currently the Vice President of Process Chemistry at DICE Therapeutics since 2022. Prior to that, from 2016 to 2022, they worked as a Senior Director of Process Chemistry at ProNAi Therapeutics, a clinical stage drug development company focused on cancer treatment. From 2011 to 2016, Mike held the role of US Sales West at CARBOGEN AMCIS AG, a leading provider of drug development services. Before that, from 2001 to 2011, they served as the Director of Manufacturing & Pharmaceutical Operations at Cylene Pharmaceuticals, overseeing CMC activities and process development. Mike also has experience as a Senior Scientist at Neurocrine Biosciences, where they focused on CNS targets, and as a Graduate Student at UCSB.

Mike Schwaebe earned a PhD in Organic Chemistry from UC Santa Barbara in the years 1992 to 1996. Prior to that, they completed their undergraduate studies in Natural Science at San Diego State University. Further details about their education prior to attending San Diego State University, such as the duration and degree obtained, are not provided in the chronological information.